<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Urinary Incontinence • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Urinary Incontinence • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/Urinary incontinence/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/Urinary incontinence/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="urinary-incontinence" tabindex="-1">Urinary incontinence</h1>
<hr>
<!-- urinary incontinence types, sx, rx -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200316201302122.png" alt=""></p>
<ul>
<li>pathogenesis
<ul>
<li>stress: decreased urethral sphincter tone, urethral hypermobility</li>
<li>urge: detrusor hyperactivity</li>
<li>overflow: impaired detrusor contractility (DM), bladder outlet obstruction</li>
</ul>
</li>
<li>treatment
<ul>
<li>Stress: kegel, pessary, pelvic floor surgery</li>
<li>Urge: Antimuscarinic (Oxybutynin)</li>
<li>Overflow: Muscarinc (Bethanechol, catherterization)</li>
</ul>
</li>
</ul>
<p>Risk factors for urinary incontinence include increased age, history of multiple vaginal deliveries, obesity, vaginal atrophy, tobacco use, and caffeine intake.</p>
<p>The initial evaluation of patients with urinary incontinence involves a thorough <strong>history</strong>, <strong>physical examination</strong>, and <strong>urinalysis</strong>. Reversible underlying causes of urinary incontinence (eg, excessive fluid intake, stool impaction, medications, delirium) are identified. Physical examination assesses for <a href="/wiki/notes/vulvovaginal%20atrophy/">vulvovaginal atrophy</a>, <a href="/wiki/notes/vesicovaginal%20fistula/">vesicovaginal fistula</a>, pelvic masses, pelvic organ prolapse, and <a href="/wiki/notes/urethral%20hypermobility/">urethral hypermobility</a>. A bladder stress test (leakage of urine with cough/Valsalva) is performed for evaluation of stress urinary incontinence, as with this patient. Urinalysis evaluates for underlying pathology, including infection or malignancy.</p>
<p>For the majority of patients (including this patient, who has stress incontinence), the initial evaluation is sufficient to classify the type of uncomplicated urinary incontinence (eg, stress, urgency, overflow) and <strong>no further evaluation is indicated</strong>. Further evaluation is indicated only if the history, physical examination, or **urinalysis suggest complicated incontinence (eg, mixed) or underlying pathology.</p>
<p>Urge incontinence: Although the detrusor overactivity is typically idiopathic, it can be caused by neurologic disease (eg, multiple sclerosis) or bladder abnormalities.  Risk factors for urgency incontinence include increasing age, stroke, depression, diabetes mellitus, obesity, caffeine intake, and tobacco abuse.</p>
<p>Overflow incontinence is typically a complication of poorly controlled diabetes mellitus (eg, diabetic neuropathy) and presents with constant urinary dribbling from incomplete bladder emptying. Patients with features of overflow incontinence (eg, peripheral or perineal neuropathy) are evaluated with a post-void residual volume (&gt;200 mL is diagnostic of overflow incontinence). Additional evaluation with a hemoglobin A1c can be performed to either diagnose diabetes mellitus or assess blood glucose control. This patient has no features of overflow incontinence; therefore, neither a post-void residual volume nor hemoglobin A1c is indicated.</p>
<p>Urodynamic testing evaluates urethral and bladder function and pressure and is indicated in the evaluation of mixed or complicated urinary incontinence.</p>
<p>Patients who have no improvement in their urgency incontinence symptoms despite <strong>lifestyle modifications</strong> (eg, bladder training) may benefit from the addition of an <strong>antimuscarinic medication</strong> such as <strong>tolterodine</strong>, <strong>solifenacin</strong>, or <strong>oxybutynin</strong>. Antimuscarinic medications improve bladder capacity and inhibit detrusor muscle contraction during bladder filling by blocking acetylcholine release in the bladder. The anticholinergic properties of these medications frequently result in side effects (eg, dry mouth, constipation, drowsiness, blurry vision) that may limit their usefulness. To minimize these side effects, antimuscarinics are initiated at the lowest dose and titrated up as tolerated. Patients with persistent incontinence symptoms despite the use of antimuscarinic medication can be considered for botulinum toxin injections or percutaneous tibial nerve stimulation.</p>
<!-- pessary vs sling -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200721211742677.png" alt=""></p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200821053716183.png" alt=""></p>
<p>A mid-urethral sling procedure is indicated in the management of stress urinary incontinence, which presents with involuntary leakage of urine associated with increased intraabdominal pressure. Patients with stress incontinence have a positive cough-stress test (ie, leakage with coughing).</p>
<p>The sling (tape) is made from a mesh of artificial material. When the tension of the tape is changed, urine should no longer leak.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/OBGYN/" class="peer">OBGYN</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <hr>
<h2 id="date%3A-2020-09-07" tabindex="-1">date: 2020-09-07</h2>
<h1 id="obgyn" tabindex="-1">OBGYN</h1>
<ul>
<li>Keywords: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<h2 id="ob" tabindex="-1">OB</h2>
<p>OB:</p>
<ul>
<li><a href="/wiki/notes/Normal%20pregnancy/">Normal pregnancy</a></li>
<li><a href="/wiki/notes/Folic%20acid%20in%20pregnancy/">Folic acid in pregnancy</a></li>
<li><a href="/wiki/notes/HPV%20and%20pregnancy/">HPV and pregnancy</a></li>
<li><a href="/wiki/notes/Labor%20in%20Pregnancy/">Labor in Pregnancy</a></li>
<li><a href="/wiki/notes/Postpartum%20thyroiditis/">Postpartum thyroiditis</a></li>
<li><a href="/wiki/notes/Infertility/">Infertility</a></li>
<li><a href="/wiki/notes/Infections%20in%20Pregnancy/">Infections in Pregnancy</a></li>
<li><a href="/wiki/notes/Choriocarcinoma/">Choriocarcinoma</a></li>
<li><a href="/wiki/notes/Cervical%20insufficiency/">Cervical insufficiency</a></li>
<li><a href="/wiki/notes/Abortions/">Abortions</a></li>
<li><a href="/wiki/notes/excercise%20in%20prenancy/">excercise in prenancy</a></li>
<li><a href="/wiki/notes/Peripartum%20Cardiomyopathy/">Peripartum Cardiomyopathy</a></li>
<li><a href="/wiki/notes/Seizure%20in%20pregnancy/">Seizure in pregnancy</a></li>
<li><a href="/wiki/notes/Rh%20Autoimmunization/">Rh Autoimmunization</a></li>
<li><a href="/wiki/notes/Thyroid%20in%20pregnancy/">Thyroid in pregnancy</a></li>
<li>[[Ectop</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
